Organogenesis Holdings (ORGO) Construction in Progress (2023 - 2025)
Organogenesis Holdings (ORGO) posted quarterly Construction in Progress of $26.7 million for Q4 2025, up 22.19% year-over-year from $21.9 million in Q4 2024, and down 2.9% quarter-over-quarter from $27.5 million in Q3 2025.
Organogenesis Holdings (ORGO) Construction in Progress (2023 - 2025) Analysis & Trends
Organogenesis Holdings' Construction in Progress history runs 3 years deep, the most recent figure standing at $26.7 million for Q4 2025.
- In Q4 2025, Construction in Progress rose 22.19% year-over-year to $26.7 million; the TTM figure through Dec 2025 stood at $26.7 million (up 22.19% YoY), while the FY2025 annual figure was $26.7 million, up 22.19% from the prior year.
- Construction in Progress for Q4 2025 stood at $26.7 million, down from $27.5 million in the prior quarter.
- The five-year high for Construction in Progress was $59.1 million in Q4 2023, with the low at $20.6 million in Q3 2024.
- The 3-year median for Construction in Progress is $23.9 million (2025), against an average of $29.1 million.
- The sharpest annual moves came in 2024 and 2025: Construction in Progress slumped 62.95% in 2024, then soared 33.66% in 2025.
- Organogenesis Holdings' Construction in Progress stood at $59.1 million in 2023, then plunged by 62.95% to $21.9 million in 2024, then gained by 22.19% to $26.7 million in 2025.
- Business Quant data shows ORGO's Construction in Progress at $26.7 million in Q4 2025, $27.5 million in Q3 2025, and $23.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.74 Mn |
| Sep 30, 2025 | 27.54 Mn |
| Jun 30, 2025 | 23.94 Mn |
| Mar 31, 2025 | 23.76 Mn |
| Dec 31, 2024 | 21.89 Mn |
| Sep 30, 2024 | 20.61 Mn |
| Dec 31, 2023 | 59.07 Mn |